Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
Purpose.
This funding opportunity announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications that propose to develop novel pharmacologic agents for brain research related to mental disorders, including research aimed at discovering new drugs for these disorders.
In addition, this FOA solicits SBIR grant applications that propose to take existing, promising compounds through the next step of drug discovery and development.
Finally, this FOA also encourages SBIR grant applications designed to study the effectiveness of novel interventions.
Mechanism of Support.
This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications.
Funds Available and Anticipated Number of Awards.?Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.?The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.
Budget and Project Period.
Phase I awards normally may not exceed $100,000 total for a period normally not to exceed 6 months.
Phase II awards normally may not exceed $750,000 total for a period normally not to exceed 2 years.
However, for this funding opportunity, budgets up to $350,000 total costs per year and time periods up to two years for Phase I may be requested.
Budgets up to $600,000 total costs per year and up to three years may be requested for Phase II.
Eligible Institutions/Organizations:
Only United States SBCs are eligible to receive SBIR applications.
A SBC is one that, on the date of award for both Phase I and Phase II funding agreements, meets ALL of the criteria as described in Section III.
Eligible Project Directors/Principal Investigators:
Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their organization to develop an application for support.
Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
On an SBIR application, the PD/PI must have his/her primary employment (more than 50%) with the SBC at the time of award and for the duration of the project.
Number of Applications:
Applicant SBCs may submit more than one application, provided each application is scientifically distinct.
Resubmissions:?Applicants may submit a ?resubmission? application, but such application must include an Introduction addressing the previous peer review critique (Summary Statement).
Number of PDs/PIs.
More than one PD/PI, or multiple PDs/PIs, may be designated on the application.
This funding opportunity announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications that propose to develop novel pharmacologic agents for brain research related to mental disorders, including research aimed at discovering new drugs for these disorders.
In addition, this FOA solicits SBIR grant applications that propose to take existing, promising compounds through the next step of drug discovery and development.
Finally, this FOA also encourages SBIR grant applications designed to study the effectiveness of novel interventions.
Mechanism of Support.
This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications.
Funds Available and Anticipated Number of Awards.?Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.?The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.
Budget and Project Period.
Phase I awards normally may not exceed $100,000 total for a period normally not to exceed 6 months.
Phase II awards normally may not exceed $750,000 total for a period normally not to exceed 2 years.
However, for this funding opportunity, budgets up to $350,000 total costs per year and time periods up to two years for Phase I may be requested.
Budgets up to $600,000 total costs per year and up to three years may be requested for Phase II.
Eligible Institutions/Organizations:
Only United States SBCs are eligible to receive SBIR applications.
A SBC is one that, on the date of award for both Phase I and Phase II funding agreements, meets ALL of the criteria as described in Section III.
Eligible Project Directors/Principal Investigators:
Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their organization to develop an application for support.
Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
On an SBIR application, the PD/PI must have his/her primary employment (more than 50%) with the SBC at the time of award and for the duration of the project.
Number of Applications:
Applicant SBCs may submit more than one application, provided each application is scientifically distinct.
Resubmissions:?Applicants may submit a ?resubmission? application, but such application must include an Introduction addressing the previous peer review critique (Summary Statement).
Number of PDs/PIs.
More than one PD/PI, or multiple PDs/PIs, may be designated on the application.
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: Not Available
Office: National Institutes of Health
Estimated Funding: Not Available
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PA-08-142.html
Additional Information of Eligibility:
Other Eligible Applicants include the following:
1.
Organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor;
2.
In the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there can be no more than 49 percent participation by business entities in the joint venture;
3.
At least 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, or it must be a for-profit business concern that is at least 51% owned and controlled by another for-profit business concern that is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States -- (except in the case of a joint venture);
4.
Has, including its affiliates, not more than 500 employees and meets the other regulatory requirements found in 13 C.F.R.
Part 121.
Business concerns, other than investment companies licensed, or state development companies qualifying under the Small Business Investment Act of 1958, 15 U.S.C.
661, et seq., are affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PA-08-142.html
Contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
FBOWebmaster@OD.NIH.GOV
Date Posted:
2008-04-10
Application Due Date:
2011-05-07
Archive Date:
2011-06-07
Social Entrepreneurship
Spotlight
Black Country Social Enterprises Bag SEWM Awards
Social enterprise triumvirate from the Black Country were recognized as the main winners at the Social Enterprise West Midlands (SEWM)-backed event.
Learn How to Identify and Avoid Grant Scams
